Literature DB >> 35571765

Highly Efficient Separation of Ultratrace Radioactive Copper Using a Flow Electrolysis Cell.

Yumi Sugo1, Shin-Ichi Ohira2, Hinako Manabe3, Yo-Hei Maruyama3, Naoaki Yamazaki4, Ryoma Miyachi2, Kei Toda2, Noriko S Ishioka1, Masanobu Mori3.   

Abstract

Preparing compounds containing the radioisotope 64Cu for use in positron emission tomography cancer diagnostics is an ongoing area of research. In this study, a highly efficient separation method to recover 64Cu generated by irradiating the target 64Ni with a proton beam was developed by employing a flow electrolysis cell (FE). This system consists of (1) applying a reduction potential for the selective adsorption of 64Cu from the target solution when dissolved in HCl and (2) recovering the 64Cu deposited onto the carbon working electrode by desorbing it from the FE during elution with 10 mmol/L HNO3, which applies an oxidation potential. The 64Cu was selectively eluted at approximately 30 min under a flow rate of 0.5 mL/min from the injection to recovery. The newly developed flow electrolysis system can separate the femtomolar level of ultratrace radioisotopes from the larger amount of target metals as an alternative to conventional column chromatography.
© 2022 The Authors. Published by American Chemical Society.

Entities:  

Year:  2022        PMID: 35571765      PMCID: PMC9096931          DOI: 10.1021/acsomega.2c00828

Source DB:  PubMed          Journal:  ACS Omega        ISSN: 2470-1343


Cancer is a major cause of death in economically developed countries.[1,2] Thus, there have been many studies on cancer treatment methods such as surgery,[3] radiotherapy,[4] and chemotherapy.[5] Advanced cancer is characterized by invasion and metastasis; therefore, the early detection of cancer is important to improve outcomes. Many techniques that enable an early diagnosis of cancer have been developed.[6−10] However, when patients are exposed to X-rays and radiation for diagnosis, it sometimes places a heavy burden on the body. Positron emission tomography (PET)[11] is one of the less burdensome diagnostic imaging methods. PET can measure primary and metastatic lesions of cancer throughout the whole body at one time with relatively small exposure to the radiation, while X-ray examination measures partial parts of the human body such as lungs and stomach with a single measurement. In PET, l-methionine labeled with 11C (11C-MET) or glucose labeled with 18F (18F-FDG) is injected into the body as a radioactive isotope. These compounds can be prepared with a small cyclotron in hospitals. When 11C-MET[12] and 18F-FDG[13] accumulate in cancer cells, they emit radiation, allowing PET to measure the location and size of the tumor. However, because these radioactive elements have a short half-life (18F: 109.77(5) m; 11C: 20.364(14) m), they are not suitable for use with drugs, such as antibodies, that take a long time to accumulate in tumors. If radiopharmaceuticals could be rapidly prepared and, moreover, entirely in a closed flow system, i.e., from the separation through drug synthesis, then the loss of radioactivity could be alleviated, thereby contributing to more effective diagnosis and treatment methods. The use of 64Cu, a copper radioisotope with a moderately long half-life (12.701(2) h), has recently been investigated as one of RI alternating to 18F or 11C.[14−16] Because copper can be stably complexed with a variety of compounds, including 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA), it has been widely used in clinical trials of PET diagnostics.[17] Also, Yoshii et al. reported that Cu-cetuximab was injected into a model mouse and successfully visualized pancreatic cancer smaller than 1 cm by a PET system equipped with a three-dimensional (3D) radiation detector.[18] Thus, utilizing 64Cu has increased as the attractive RI metal in PET diagnosis. However, because the radiation intensity of the produced nuclides has decreased by the time of clinical use, the shortest possible process time from 64Cu production to drug synthesis (as described below) has been required. The production steps include: Production of pico- or nanomole levels of 64Cu by irradiating 64NiO or 64Ni metal with a proton beam. Dissolution of the irradiated samples with hydrochloric acid and heating. Separation of 64Cu from the 64Ni matrix by column chromatography. Removal of hydrochloric acid by evaporation to dryness. The process (1) takes 1–5 h, depending on the amount of RI–Cu required.[19,20] The processes (2)–(4) related to the separation and purification of 64Cu take approximately 2.5–4 h, i.e., 1–2 h in process (2), 15–30 min in process (3), and 1–2 h in process (4), though the required times for the processes are different among the research groups.[19,20] The attenuation factor of the 64Cu (f) during processes (2)–(4) estimated from eq is reduced to 0.80–0.87, assuming an initial radioactivity of 1where T is half-life, t is the attenuation time, A0 is the initial radioactivity, and A is the radioactivity to attenuation time. The manufacturing process can be fully automated to avoid radioactive contamination and radiation exposure to workers.[21] However, to prevent the loss of radiation intensity, rapid and highly efficient separation, purification, and drug synthesis methods are required. Our group recently developed a drug synthesis process using an electrodialytic ion-transfer device (ITD).[22] This device was first developed by Ohira et al.[23] and has been applied to extract inorganic anions,[24] enable chromium speciation,[25] and separate weak acids.[26] The ITD was used to demonstrate in-line probe synthesis using DOTA and 1.0 pmol/L 64Cu2+. The advantage of this process is that the desired drug can more rapidly be obtained because it eliminates the evaporation to dryness step, which takes time to completely remove the strong acid in the aqueous solution. However, in the previous work, the separation of 64Cu from a large amount of 64Ni matrix in the irradiated solid sample was still required. In the current study, we developed an effective technique for separating 64Cu from the 64Ni matrix using electrolysis instead of the conventional method in which 64Cu is separated from 64Ni via a chelating or an ion-exchange resin column; however, the 64Cu product still needs to be concentrated after separation. Electrolysis can selectively separate 64Cu from the 64Ni matrix by controlling the redox potential in a handheld-sized flow electrolysis cell (FE). The separation is based on the electrochemical nature of Cu, which preferentially undergoes reduction compared with Ni.[27] The FE adsorbs zerovalent Cu (Cu0) and eliminates the Ni matrix by applying a reduction potential; divalent Cu (Cu2+) is then desorbed by applying an oxidation potential during which acid eluent is flowed through the FE. This study preliminarily reports that the flow electrolysis method can achieve a highly efficient separation of ultratrace 64Cu produced from irradiating 64NiO with a proton beam under conditions that were optimized for the stable isotope Cu2+.

Experimental Section

Flow Electrolysis Cell

In this initial investigation of separating Cu from Ni via electrolysis, we employed the VF2 flow electrolysis cell from EC Frontier, Co., Ltd. (Kyoto, Japan) (Figure a). The working electrode was a carbon felt electrode (Φ18 mm, volume: 130 mm3, effective surface area: 1900 cm2) because it enabled the efficient adsorption of the target element. The electrode was fabricated from high-density carbon fibers; the fibers are intertwined with each other, as shown in the scanning electron microscopy (SEM) image in Figure S1. Copper that is passed through the FE when a reduction potential is applied adsorbs to the surface of the fiber electrode (Figures and S1). The current variations when applying the constant voltage to the FE for each faction were monitored by connecting the digital multimeter (PC7000, Sanwa Electric Instrument, Co., Ltd. Tokyo, Japan) to the electrodes of the FE. The variations were displayed by a PC that installed the PC Link 7 version 4.1 (Sanwa Electric Instrument, Co., Ltd.).
Figure 1

Schematic of the flow electrolysis cell: (a) overview of the FE and (b) electrodeposition and recovery of Cu2+ from the Ni2+ matrix.

Schematic of the flow electrolysis cell: (a) overview of the FE and (b) electrodeposition and recovery of Cu2+ from the Ni2+ matrix.

Procedures

Applying a reduction potential to the FE reduced the Cu2+ and deposited it onto the working electrode as a simple substance. Because of the difference in standard potentials (ECu° = +0.340 V, ENi° = −0.257 V),[28] the Ni matrix was kept as its ionic form, Ni2+. Applying an oxidation potential with flowing 10 mmol/L HNO3 eluted the deposited Cu. A schematic of the procedure is provided in Figure b. In this study, we defined a four-step procedure as follows: the adsorption of Cu2+ to the FE (fraction 1, F1); flushing remaining sample solution from the FE (fraction 2, F2); recovery of Cu2+ from the FE (fraction 3, F3); and washing the residue from the FE (fraction 4, F4). The effluent of each fraction was separately collected and analyzed to evaluate the performance. The electrodeposition rates (ED) of Cu2+ and Ni2+ were estimated by eq where nint (mol) is the initial amount of metal (Cu2+ or Ni2+), and nF1 (mol) is the amount in the effluent that passed through the FE (i.e., F1). The amount of Cu2+ adsorbed by the FE (nads, mol) was estimated by eq The recovery (R) of Cu2+ that was adsorbed by the FE was calculated using eq where nF3 (mol) is the amount of metal in the effluent when eluting with 10 mmol/L HNO3 (F3).

Optimization of Cu Separation Conditions in a Cold Test

The experimental conditions applied voltage and flow rate were optimized with a stable isotope experiment cold test. The sample solutions containing stable isotopes were prepared from a copper standard solution (Cu(NO3)2 in 0.1 mol/L HNO3) and a nickel standard solution (Ni(NO3)2 in 0.1 mol/L HNO3) (Fujifilm Wako Pure Chemical Industries, Tokyo, Osaka). The stable isotope samples were 0.1 mol/L HCl solutions containing 200 μg/L Cu2+ and 200 mg/L Ni2+. The samples were flowed into the FE using a peristaltic pump at a rate of 0.5–1.0 mL/min. For Cu2+ adsorption, −0.8–0 V (vs Ag/AgCl) was applied to the FE; for its recovery, 0–1.0 V (vs Ag/AgCl) was applied. The voltage applied to the FE was controlled by a potentiostat (HA-151B, Hokuto Denko, Co., Ltd. Tokyo, Japan). The concentrations of Cu2+ and Ni2+ in the solution eluted from the FE were determined by a flame atomic absorption spectrometry (AAnalyst 200, Perkin Elmer, Waltham, MA) and inductively coupled plasma mass spectrometry (ICP-MS, Agilent 7500cx ICP-MS, Agilent Technology, Santa Clara, CA). Their analytical conditions are summarized in Table S1.

Sample Preparation in a Hot Test

64Cu was obtained by irradiating the isotopically enriched 64NiO target (Isoflex, San Francisco, CA) with a proton beam at Takasaki Ion Accelerators for Advanced Radiation Application facility in the National Institute for Quantum Science and Technology, Takasaki, Japan. The irradiated sample was dissolved in HCl with heating, and the generated 64Cu was separated as described previously.[29,30] In the current study, as a tracer of the Ni matrix, 57Ni (half-life: 35.60(6) h) was prepared as follows: (1) proton beam irradiation of natural Ni metal, (2) dissolution of the irradiated Ni in 6 mol/L HCl with heating, (3) evaporation to dryness, and (4) dissolution in ultrapure water. The initial concentrations of the test solution were 300 fmol/L 64Cu and 3.1 mmol/L Ni (including 400 fmol/L 57Ni as the tracer) in 0.1 mol/L HCl.

Separation of 64Cu in a Hot Test

Prior to the electrodeposition of 64Cu, 0.1 mol/L HCl was flowed into the FE, applying −0.8 V (vs Ag/AgCl) to the FE by a potentiostat. Next, the test solution of 5 mL was flowed into the FE using a peristaltic pump at a flow rate of 0.5 mL/min. Subsequently, 5 mL of 0.01 mol/L HNO3 was flowed into the FE under the same conditions; this procedure gave F1. The sample solution remaining in the FE was then flushed out with 10 mmol/L HNO3 (5 mL) at a flow rate of 0.5 mL/min while applying −0.8 V. This procedure produced F2. The Cu deposited in the FE was eluted with 0.01 mol/L HNO3 (5 mL) at a flow rate of 0.5 mL/min while applying +1.0 V (vs Ag/AgCl). This procedure gave F3. Finally, 0.1 mol/L HCl (5 mL) was used to flush any residue from the FE in preparation for the next test. This procedure generated F4. The radioactivity of 64Cu and 57Ni in each fraction was measured by a NaI (Tl) scintillation detector (AccuFLEX γ 7001, Hitachi Co., Ltd.). The chemical compositions of the effluent samples that were collected after electrodeposition (F1) and after recovery (F3) were measured by a Ge semiconductor detector coupled to a multichannel analyzer (7800 MCA, Seiko EG&G).

Results and Discussion

Selective Deposition and Recovery of Stable Cu in the Cold Test

In the present method, the applied potential is the key to enable the separation. Thus, the applied potential was first optimized by the cold test. The electrodeposition of 200 μg/L Cu2+ and 200 mg/L Ni2+ onto the working electrode in the FE was observed when applying a reduction potential in the range of −0.8–0 V. As shown in Figure a, more than 97% of the Cu2+ was adsorbed to the FE over the range of −0.8 to −0.5 V, while almost all of the Ni2+ was excluded from adsorption. As mentioned above, this result was expected because zerovalent Cu is adsorbed onto the working electrode when applying a reduction potential, while divalent Ni flows through the FE.
Figure 2

Effects of applied potential on (a) electrodeposition rate (ED) of Ni2+ and Cu2+ by applying a negative potential and (b) recovery (R). Injected solution: (a) 200 μg/L Cu(NO3)2 and 200 mg/L Ni(NO3)2 in 0.1 mol/L HCl, (b) 10 mmol/L HNO3. Flow rate: 0.5 mL/min in both the electrodeposition and recovery operations. Sample volume: 5 mL. A volume of 10 mmol/L HNO3 was used to flush out the residue (F2): 5 mL. A volume of 10 mmol/L HNO3 was used to desorb the Cu from the FE (F3): 5 mL.

Effects of applied potential on (a) electrodeposition rate (ED) of Ni2+ and Cu2+ by applying a negative potential and (b) recovery (R). Injected solution: (a) 200 μg/L Cu(NO3)2 and 200 mg/L Ni(NO3)2 in 0.1 mol/L HCl, (b) 10 mmol/L HNO3. Flow rate: 0.5 mL/min in both the electrodeposition and recovery operations. Sample volume: 5 mL. A volume of 10 mmol/L HNO3 was used to flush out the residue (F2): 5 mL. A volume of 10 mmol/L HNO3 was used to desorb the Cu from the FE (F3): 5 mL. The deposition and recovery of Cu in the FE did not significantly change over the flow rate range of 0.2–1.0 mL/min (Figure S2). Actually, even at a flow rate of 2.0 mL/min, the effective electrodeposition of Cu2+ was achieved (Figure S3). However, the slight deposition of Ni2+ to FE or the unstable recovery of Cu2+ was obtained. In the hot test, the flow rate was set to 0.5 mL/min to ensure quantitative and stable Cu2+ adsorption onto the working electrode. We next attempted to desorb the Cu2+ that was deposited onto the working electrode. The eluent was 10 mmol/L HNO3 and was flowed at 0.5 mL/min. Cu was eluted even without the applied potential because the Cu deposited in the FE was dissolved by the HNO3. The best recovery efficiency of Cu2+ was obtained when +1.0 V was applied to the FE (Figure b), where the R estimated from eq was 95 ± 5%. The concentration of HNO3 as the eluent was tested at 1 and 100 mmol/L, and the Cu was completely eluted in the range from 10 to 100 mmol/L solution. However, the HNO3 concentration should be as low as possible considering the electrical load on the FE and the drug synthesis after recovery. From these results, the optimal applied voltage (Vapp) was concluded to be −0.8 V for the deposition of Cu in the FE, a Vapp of +1.0 V for recovery, 10 mmol/L HNO3 as the eluent, and a sample and eluent flow rate of 0.5 mL/min. In addition, the eluent to recover Cu2+ deposited into the FE can be used by a lower acid concentration compared to the column chromatographic method (e.g., >0.1 M HCl).[19,20,31] In this method, the Cu recovery from the FE can also be obtained by HCl, citric acid, or acetic acid (10 mM each), as shown in Figure S4. Next, we optimized the volumes flowed during flushing (F2), Cu recovery (F3), and washing (F4) when 5 mL of sample containing Cu2+ and Ni2+ was flowed through the FE (F1). The solution volume directly affects the concentration of 64Cu in the separated solution. It is also important to minimize the radioactive waste. Each fraction was separately collected every 5 mL. As shown in Figure , no Cu2+ was eluted in F1 or F2 while Ni2+ flowed through the system and was present in F1 and F2. The Cu2+ deposited in the FE was almost entirely eluted in the first 5 mL of HNO3 (F3). The Ni2+ and Cu2+ in the effluents collected in the other fractions were below the quantification limits in the ICP-MS used in this study. The volume flowed for each fraction was 5 mL each from F2 to F4. The average concentrations of metals for each fraction were 195.1 ± 4.1 mg/L of Ni2+ in F1, 5.2 ± 0.8 mg/L of Ni2+ in F2, and 198.4 ± 1.1 μg/L of Cu2+ in F3 at three consecutive operations (Table S2).
Figure 3

Recoveries (R) of Ni2+ and Cu2+ eluted in the four fractionation procedures. A sample volume of 5 mL (0.1 mol/L HCl containing 20 μg/L Cu2+ and 200 mg/L Ni2+) was flowed into the FE (F1); 20 mL of 10 mmol/L HNO3 was used to flush the sample residue from the FE (F2); 20 mL of 10 mmol/L HNO3 was used to elute the Cu from the FE (F3), and 10 mL of 0.1 mol/L HCl was used to wash the FE (F4). Flow rate: 0.5 mL/min. Applied voltage: (F1 and F2) −0.8 V, (F3) +1.0 V, and (F4) 0 V.

Recoveries (R) of Ni2+ and Cu2+ eluted in the four fractionation procedures. A sample volume of 5 mL (0.1 mol/L HCl containing 20 μg/L Cu2+ and 200 mg/L Ni2+) was flowed into the FE (F1); 20 mL of 10 mmol/L HNO3 was used to flush the sample residue from the FE (F2); 20 mL of 10 mmol/L HNO3 was used to elute the Cu from the FE (F3), and 10 mL of 0.1 mol/L HCl was used to wash the FE (F4). Flow rate: 0.5 mL/min. Applied voltage: (F1 and F2) −0.8 V, (F3) +1.0 V, and (F4) 0 V. In the present method, the time from the injection (F1) to recovery (F3) of 64Cu was 30 min at a flow rate of 0.5 mL/min, which is almost unchanged compared to that of the conventional method with column chromatography. By contrast, the elution of 64Cu from the FE could easily be achieved by eluent with a lower concentration of strong acid or a weaker acid (Figure S4), compared to the eluent used in the column chromatographic method.[19,20,31] The electrochemical oxidation/reduction may facilitate copper adsorption and desorption of Cu to the FE. The property may contribute to omitting evaporation to dryness for conversion to weak acids for radiolabeling in the conventional method, which requires the most time for separation and recovery. If the evaporation to dryness is skipped, the attenuation of 64Cu (f) estimated by eq from the time of the dissolution of the irradiated sample and separation to recovery by the present method can be suppressed to 0.87–0.88. We further monitored the variation in current as the applied potential during the entire operation. As shown in Figure S5, the current was greatly reduced when flowing 0.1 mol/L HCl containing Cu2+ and Ni2+ (F1). The reduction was larger than when flowing the blank solution (0.1 mol/L HCl only). The reduction of Cu2+ is related to the presence of protons in an acidic solution. When flushing the residue from the FE by flowing 10 mmol/L HNO3 (F3), the current was increased to −200 μA, which was similar to that of the blank. A rapid increase in current was observed when switching the polarity from negative to positive potentials to desorb the Cu from the FE (F3), but the current exponentially decreased and finally plateaued at approximately 0.5 μA.

Hot Test for Electrodeposition and Recovery of the Radioisotope 64Cu

A hot test with the radioisotope was performed. Radioisotopes can be detected even at the femtomolar level. In the present study, we found that the separation mechanism was effective at ultratrace levels of Cu. The 0.1 mol/L HCl solutions (5 mL) containing 300 fmol/L 64Cu2+ (1.5 fmol) and 3.1 mmol/L Ni2+ (including 400 fmol/L 57Ni2+ as the tracer) were injected into the FE under the optimized conditions found in the stable isotope experiments. During 64Cu2+ electrodeposition (F1), Ni2+ was quantitatively eluted, while 64Cu2+ was selectively adsorbed in the FE (Figure ). When the residue was flushed from the FE (F2), no 64Cu2+ or Ni2+ elution was observed. This indicated that the quantitative deposition of 64Cu and the elimination of 64Ni quantitatively occurred during the F1 procedure. During recovery (F3), 64Cu was quantitatively desorbed from the FE by changing the voltage to +1.0 V (1st 64Cu recovery: 99.3%, 2nd: 100.3%). Finally, during the washing procedure without any applied voltage (F4), no 64Cu2+ or Ni2+ elution was observed.
Figure 4

Recoveries of Ni matrix (57Ni as the tracer) and 64Cu in four fractions collected from the FE. Injected sample solutions: 300 fmol/L 64Cu2+ and 3.1 mmol/L 64Ni2+ (including 400 fmol/L 57Ni2+ as the tracer) in 0.1 mol/L HCl. Eluent: 10 mmol/L HNO3. Flow rate: 0.5 mL/min in both the electrodeposition and recovery operations. Sample volume: 5 mL. Volumes for F2–F4: 5 mL each.

Recoveries of Ni matrix (57Ni as the tracer) and 64Cu in four fractions collected from the FE. Injected sample solutions: 300 fmol/L 64Cu2+ and 3.1 mmol/L 64Ni2+ (including 400 fmol/L 57Ni2+ as the tracer) in 0.1 mol/L HCl. Eluent: 10 mmol/L HNO3. Flow rate: 0.5 mL/min in both the electrodeposition and recovery operations. Sample volume: 5 mL. Volumes for F2–F4: 5 mL each. The obtained solutions in each protocol were also measured using a Ge semiconductor. The γ-ray spectra were obtained from the sample solution before injection into the FE (Figure a). The solution eluted as F1 contained 57Ni (Figure b), while not containing 64Cu. The effluent when 10 mmol/L HNO3 was used to flush the FE (F2) did not contain either 64Cu or 57Ni (Figure c). The F3 effluent contained only 64Cu (Figure d). These results show that the selective and highly efficient separation of ultratrace 64Cu was successfully achieved. On the other hand, 55Co, which is a byproduct generated by producing 57Ni, was eluted in the F1 but was not eluted in F2 or F3. Because E° of Co2+ is −0.277 V,[28]55Co2+ was eluted by the procedures in the F1 as well as Ni2+. In addition, stable Ni in the F3 was below the limit of quantification (<0.27 μg L–1) by the ICP-MS used in this study.
Figure 5

γ-ray spectra of FE effluents as determined by a Ge semiconductor detector. (a) A mixture of 57Ni and 64Cu in 0.1 mol/L HCl before injecting into the FE, (b) effluent after passing the solution through the FE by applying −0.8 V (F1), (c) effluent after flushing any remaining sample by flowing 10 mmol/L HNO3 through the FE with applying −0.8 V (F2), and (d) effluent when flowing 10 mmol/L HNO3 with applying +1.0 V (F3).

γ-ray spectra of FE effluents as determined by a Ge semiconductor detector. (a) A mixture of 57Ni and 64Cu in 0.1 mol/L HCl before injecting into the FE, (b) effluent after passing the solution through the FE by applying −0.8 V (F1), (c) effluent after flushing any remaining sample by flowing 10 mmol/L HNO3 through the FE with applying −0.8 V (F2), and (d) effluent when flowing 10 mmol/L HNO3 with applying +1.0 V (F3). Accordingly, in the results of the hot test, 64Cu was not eluted in F2, and the separation is more efficient compared with those of the cold test. The high purity of 64Cu was concluded to be recovered in F3 of the present procedures and without the need for heating and evaporation to dryness.

Conclusions

The flow electrolysis cell was able to selectively separate and recover femtomolar levels of 64Cu. This method can thus be used as an alternative electrochemical separation method to conventional chromatographic separation. The developed method will contribute to the efficient manufacturing of PET diagnostic materials because the electrochemical procedures do not require evaporation to dryness. Therefore, we believe that this electrochemical technique will be applied in radioactive isotope medical technologies.
  28 in total

1.  Electrodialytic ion isolation for matrix removal.

Authors:  Shin-Ichi Ohira; Kenta Kuhara; Mayu Kudo; Yuko Kodama; Purnendu K Dasgupta; Kei Toda
Journal:  Anal Chem       Date:  2012-06-07       Impact factor: 6.986

2.  64Cu-DOTA-trastuzumab PET imaging in patients with HER2-positive breast cancer.

Authors:  Kenji Tamura; Hiroaki Kurihara; Kan Yonemori; Hitoshi Tsuda; Junko Suzuki; Yuzuru Kono; Natsuki Honda; Makoto Kodaira; Harukaze Yamamoto; Mayu Yunokawa; Chikako Shimizu; Koki Hasegawa; Yousuke Kanayama; Satoshi Nozaki; Takayuki Kinoshita; Yasuhiro Wada; Shusaku Tazawa; Kazuhiro Takahashi; Yasuyoshi Watanabe; Yasuhiro Fujiwara
Journal:  J Nucl Med       Date:  2013-09-12       Impact factor: 10.057

3.  The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines.

Authors:  Geoff Delaney; Susannah Jacob; Carolyn Featherstone; Michael Barton
Journal:  Cancer       Date:  2005-09-15       Impact factor: 6.860

4.  Implementation of a new separation method to produce qualitatively improved 64 Cu.

Authors:  Nicholas P van der Meulen; Roger Hasler; Alain Blanc; Renata Farkas; Martina Benešová; Zeynep Talip; Cristina Müller; Roger Schibli
Journal:  J Labelled Comp Radiopharm       Date:  2019-06-30       Impact factor: 1.921

5.  High Enantiomeric Excess In-Loop Synthesis of d-[methyl-11C]Methionine for Use as a Diagnostic Positron Emission Tomography Radiotracer in Bacterial Infection.

Authors:  Megan N Stewart; Matthew F L Parker; Salma Jivan; Justin M Luu; Tony L Huynh; Brailee Schulte; Youngho Seo; Joseph E Blecha; Javier E Villanueva-Meyer; Robert R Flavell; Henry F VanBrocklin; Michael A Ohliger; Oren Rosenberg; David M Wilson
Journal:  ACS Infect Dis       Date:  2019-11-21       Impact factor: 5.084

6.  Production of therapeutic quantities of (64)Cu using a 12 MeV cyclotron.

Authors:  Atsushi Obata; Shingo Kasamatsu; Deborah W McCarthy; Michael J Welch; Hideo Saji; Yoshiharu Yonekura; Yasuhisa Fujibayashi
Journal:  Nucl Med Biol       Date:  2003-07       Impact factor: 2.408

7.  Electrodialytic Handling of Radioactive Metal Ions for Preparation of Tracer Reagents.

Authors:  Yumi Sugo; Ryoma Miyachi; Yo-Hei Maruyama; Shin-Ichi Ohira; Masanobu Mori; Noriko S Ishioka; Kei Toda
Journal:  Anal Chem       Date:  2020-10-05       Impact factor: 6.986

8.  Pharmacometabonomics Analysis Reveals Serum Formate and Acetate Potentially Associated with Varying Response to Gemcitabine-Carboplatin Chemotherapy in Metastatic Breast Cancer Patients.

Authors:  Limiao Jiang; Soo Chin Lee; Thian C Ng
Journal:  J Proteome Res       Date:  2018-02-12       Impact factor: 4.466

9.  Establishing Reliable Cu-64 Production Process: From Target Plating to Molecular Specific Tumor Micro-PET Imaging.

Authors:  Qinghua Xie; Hua Zhu; Feng Wang; Xiangxi Meng; Qiushi Ren; Chuanqin Xia; Zhi Yang
Journal:  Molecules       Date:  2017-04-17       Impact factor: 4.411

10.  Coordination Chemistry of Bifunctional Chemical Agents Designed for Applications in 64Cu PET Imaging for Alzheimer's Disease.

Authors:  Anuj K Sharma; Jason W Schultz; John T Prior; Nigam P Rath; Liviu M Mirica
Journal:  Inorg Chem       Date:  2017-11-07       Impact factor: 5.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.